Nuzenio

Why Newamsterdam Pharma

Why Newamsterdam Pharma news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 7 latest news signals 6 publisher sources 100/100 entity strength

Latest news

NewAmsterdam Pharma Wins CHMP Opinion for Obicetrapib Cholesterol Drug - The Clinical Trial VanguardThe Clinical Trial Vanguard · Thu, 06 Aug 2026 06:43:58 GMTNewAmsterdam Pharma reports $3.7 million second quarter revenue - Quiver QuantitativeQuiver Quantitative · Wed, 05 Aug 2026 11:16:00 GMTNewAmsterdam Pharma Co N.V. Q2 2026: Revenue $3.7M, EPS $(0.52) — 10-Q Summary - TradingViewTradingView · Wed, 05 Aug 2026 11:11:01 GMTNewAmsterdam Pharma Provides Corporate Update and Reports Second Quarter Financial Results - GlobeNewswireGlobeNewswire · Wed, 05 Aug 2026 11:00:00 GMTWhy NewAmsterdam Pharma (NAMS) Is Down 6.2% After EMA Backs Ubeslo And Evlarco Approval - webull.comwebull.com · Tue, 04 Aug 2026 00:03:28 GMTNewAmsterdam Pharma to Host Investor Day on August 5, 2026 - GlobeNewswireGlobeNewswire · Wed, 29 Jul 2026 12:00:00 GMTNewAmsterdam Pharma to Discuss Cholesterol Drug at Aug. 5 Event - Stock TitanStock Titan · Wed, 29 Jul 2026 07:00:00 GMT

Timeline

Thu, 06 Aug 2026 06:43:58 GMTNewAmsterdam Pharma Wins CHMP Opinion for Obicetrapib Cholesterol Drug - The Clinical Trial Vanguard
Wed, 05 Aug 2026 11:16:00 GMTNewAmsterdam Pharma reports $3.7 million second quarter revenue - Quiver Quantitative
Wed, 05 Aug 2026 11:11:01 GMTNewAmsterdam Pharma Co N.V. Q2 2026: Revenue $3.7M, EPS $(0.52) — 10-Q Summary - TradingView
Wed, 05 Aug 2026 11:00:00 GMTNewAmsterdam Pharma Provides Corporate Update and Reports Second Quarter Financial Results - GlobeNewswire
Tue, 04 Aug 2026 00:03:28 GMTWhy NewAmsterdam Pharma (NAMS) Is Down 6.2% After EMA Backs Ubeslo And Evlarco Approval - webull.com
Wed, 29 Jul 2026 12:00:00 GMTNewAmsterdam Pharma to Host Investor Day on August 5, 2026 - GlobeNewswire

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Why Newamsterdam Pharma.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

6 distinct publisher/source names are currently connected to this entity page.